Recent NewsView All
At Entrada, we are united in our mission to treat devastating diseases with intracellular therapeutics.
Our proprietary EEV™ Platform has the potential to reach and engage previously inaccessible and undruggable disease-causing targets within cells.
Our EEV™ Platform is highly versatile and modular, offering broad potential across therapeutic areas. We are already developing potential treatments across multiple devastating diseases, and this is just the beginning.